Brian K. Link on Muck Rack

Brian K. Link

As seen in: Wiley Online Library, The Lancet, Journal of Clinical Oncology, Texas Medical Center, Blood, Future Medicine, The Journal of Allergy & Clinical Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brian K.

Contact Brian K., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes

|
By Arushi Khurana, Hikaru Hayashi, Bethany Thach, Zhi Yang, Brianna J. Negaard, James R. Cerhan, Anne Novak, Brian K. Link, Thomas M Habermann, Andrew Feldman, Sameer A Parikh, Susan L Slager, Stephen Ansell, Matthew J. Maurer, Bethany Thach
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement These data are not publicly available. Details on how to request MER clinical data underlying the study can be found at LEOCohort.org. Supporting Information Filename Description ajh70293-sup-0001-Supinfo1.pptxPowerPoint 2007 presentation , 3.6 MB Figure S1: Lymphoma patients of all stages and subtypes have elevated serum levels of sTNFR2 and sTNFR1 relative to controls, but sTNFR1 levels are much lower.
Open in Who Shared Issue with article?

The Lymphoma Epidemiology of Outcomes Cohort Study: Design, Baseline Characteristics, and Early Outcomes

|
By James R. Cerhan, Matthew J. Maurer, Brian K. Link, Andrew Feldman
| Texas Medical Center
Abstract To address the current and long-term unmet health needs of the growing population of non-Hodgkin lymphoma (NHL) patients, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT02736357; https://leocohort.org/). A total of 7735 newly diagnosed patients aged 18 years and older with NHL were prospectively enrolled from 7/1/2015 to 5/31/2020 at 8 academic centers in the United States. The median age at diagnosis was 62 years (range, 18-99).
Open in Who Shared Issue with article?

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

|
By James R. Cerhan, Matthew J. Maurer, Brian K. Link, Andrew Feldman, Thomas M Habermann, David L. Jaye, Timothy McDonnell, Francisco Vega, Jennifer Chapman, Sergei Syrbu, Kiran Vij, Giorgio G. Inghirami, John Leo, W. Richard Burack
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description ajh27202-sup-0001-Supinfo.docxWord 2007 document , 650.2 KB Data S1. REFERENCES 1, , , . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1): 17-48. 2, , , . Non-Hodgkin lymphoma. Lancet. 2017; 390(10091): 298-310. 3 SEER*Explorer: An Interactive Website for SEER Cancer Statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2023.
Open in Who Shared Issue with article?
See all 12 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified